AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade ...

He closed by connecting payment infrastructure directly to the broader site access problem, noting that with 80% of sites ...

In this video interview, Patrick Mizer, chief technology officer at Ledger Run, describes how agentic AI is being applied to invoice processing—one of the most labor-intensive bottlenecks in site ...

In today's ACT Brief, we examine where agentic AI delivers immediate wins in site payments, how botanical therapies can earn ...

How connected workflows can improve visibility across participant activity, treatment allocation, eCOA compliance, and supply status. Why oncology studies illustrate the growing need for integrated ...

In a recent video interview with Applied Clinical Trials, Patrick Mizer, chief technology officer at Ledger Run, discussed how payment reliability has quietly become one of the mo ...

The FDA has issued a discussion paper outlining potential approaches to regulating generative artificial intelligence (GenAI) ...

In today's ACT Brief, we examine how payment reliability has become a competitive differentiator at high-performing sites, ...

In this episode of Beyond Compliance, Otis Johnson, PhD, MPA, founder and principal consultant at Vantix Operations, speaks with Joel Stanley, CEO of AJNA BioSciences, about why botanical therapies ...

In this video interview, Amber Hill, PhD, founder and CEO of Research Grid, explains why most trial failures are ...

In today's ACT Brief, we examine the three conditions required for AI-driven trial acceleration to work at scale, why agentic ...

Inspection readiness reflects how a program was actually run throughout its lifecycle, not what can be assembled at the end, making pre-submission remediation itself a signal of absent oversight ...